Bicycle Therapeutics plc
BCYC
$4.01
-$0.18-4.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 36.25% | -0.12% | 61.13% | -16.33% | -98.31% |
| Total Depreciation and Amortization | -37.09% | -30.91% | -21.60% | -19.15% | 3.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -26.08% | -19.30% | 159.09% | 10.77% | -1.70% |
| Change in Net Operating Assets | -52.57% | 63.65% | -136.25% | -2,548.86% | 70.51% |
| Cash from Operations | 31.85% | 23.67% | -105.90% | -78.68% | -63.10% |
| Capital Expenditure | 46.79% | -18.05% | -55.98% | -54.94% | -18.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 46.79% | -18.05% | -55.98% | -54.94% | -18.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.87% | -53.49% | -14.29% | 99.90% | -- |
| Issuance of Common Stock | 0.00% | 500.00% | -86.53% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -11.11% | -31.71% | -107.39% | 99.91% | -100.01% |
| Foreign Exchange rate Adjustments | -102.71% | -515.38% | 87.54% | -173.69% | 1,041.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 30.13% | 20.70% | -77.72% | -3.72% | -114.18% |